Intensity-modulated radiation therapy for early-stage breast cancer
Author Information
Author(s): Hanna Samir Abdallah, Mota Bruna Salani, de Moraes Fabio Ynoe, Marta Gustavo Nader, Carvalho Heloísa de Andrade, Riera Rachel
Primary Institution: Hospital Sírio-Libanês, São Paulo, Brazil
Hypothesis
Does intensity-modulated radiation therapy (IMRT) improve efficacy and safety in women with early-stage breast cancer compared to non-IMRT strategies?
Conclusion
IMRT improved acute toxicity and lowered telangiectasia rates, without affecting oncological and aesthetic outcomes.
Supporting Evidence
- IMRT reduced overall acute toxicity compared to conventional RT.
- Local relapse-free survival rates were not significantly different between IMRT and non-IMRT.
- IMRT showed a significant reduction in acute moist desquamation rates.
Takeaway
This study found that a special type of radiation therapy called IMRT can help reduce skin problems for women with early breast cancer, but it doesn't make the cancer treatment better overall.
Methodology
Systematic review of randomized controlled trials comparing IMRT with non-IMRT strategies, assessing local control and acute toxicity.
Potential Biases
Most studies lacked blinding and had potential attrition bias.
Limitations
Heterogeneity in treatment protocols and endpoints across included studies; low or very low certainty of evidence for most outcomes; limited follow-up duration in some studies.
Participant Demographics
Women with pathologically confirmed ductal carcinoma in situ or nonmetastatic invasive breast cancer, with a mean age of approximately 57 years.
Statistical Information
P-Value
p<0.00001
Confidence Interval
95%CI 0.58 to 0.82
Statistical Significance
p<0.00001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website